Patents by Inventor Martin SUCHAN

Martin SUCHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for characterizing loss of antigen presentation
    Patent number: 11920194
    Abstract: This invention relates to methods for screening for a genotype for loss of antigen presentation via MHC class I in a subject and/or respectively detecting a subject's increased risk of resistance against immunotherapy such as against vaccination.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: March 5, 2024
    Assignees: BioNTech SE, TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
    Inventors: Ugur Sahin, Martin Suchan, Barbara Schrörs, Martin Löwer, Petra Oehm
  • THERAPEUTIC RNA FOR PROSTATE CANCER
    Publication number: 20230114808
    Abstract: Disclosed herein are compositions, uses, and methods for treatment of prostate cancers.
    Type: Application
    Filed: March 11, 2020
    Publication date: April 13, 2023
    Inventors: David WEBER, Carina WALTER, Diana BAREA ROLDAN, Ruprecht KUNER, Elif DIKEN, Martin SUCHAN, Stefania GANGI MAURICI, Ugur SAHIN
  • THERAPEUTIC RNA FOR OVARIAN CANCER
    Publication number: 20220257631
    Abstract: Disclosed herein are compositions, uses, and methods for treatment of ovarian cancers. In one aspect, provided herein is a composition or medical preparation comprising at least one RNA, wherein the at least one RNA encodes the following amino acid sequences: (i) an amino acid sequence comprising claudin 6 (CLDN6), an immunogenic variant thereof, or an immunogenic fragment of the CLDN6 or the immunogenic variant thereof; (ii) an amino acid sequence comprising p53, an immunogenic variant thereof, or an immunogenic fragment of the p53 or the immunogenic variant thereof; and (iii) an amino acid sequence comprising Preferentially Expressed Antigen In Melanoma (PRAME), an immunogenic variant thereof, or an immunogenic fragment of the PRAME or the immunogenic variant thereof.
    Type: Application
    Filed: May 20, 2020
    Publication date: August 18, 2022
    Inventors: Ugur SAHIN, David WEBER, Carina WALTER, Diana BAREA ROLDAN, Ruprecht KUNER, Meike WAGNER, Martin SUCHAN, Stefania GANGI MAURICI, Stefanie HUBICH-RAU, René BECKER
  • METHODS FOR CHARACTERIZING LOSS OF ANTIGEN PRESENTATION
    Publication number: 20200140945
    Abstract: This invention relates to methods for screening for a genotype for loss of antigen presentation via MHC class I in a subject and/or respectively detecting a subject's increased risk of resistance against immunotherapy such as against vaccination.
    Type: Application
    Filed: June 1, 2018
    Publication date: May 7, 2020
    Inventors: Ugur SAHIN, Martin SUCHAN, Barbara SCHRÖRS, Martin LÖWER, Petra OEHM